Literature DB >> 18193316

A management strategy for mild valvar pulmonary stenosis.

David M Drossner1, William T Mahle.   

Abstract

Pulmonary valve stenosis (PVS) is a common congenital cardiac lesion, 1/1000 live-births, the majority of patients having mild transvalvar gradients. In the present study, we sought to determine the outcome of mild PVS diagnosed by echocardiography and to propose a management algorithm that would identify patients at risk for progression of PVS, yet reduce health care expenditures. In this single-center retrospective study, we included all patients who met the following criteria: first diagnosed with PVS at <10 years of age, an initial peak systolic Doppler gradient of < or =40 mm Hg, no additional congenital heart lesions, and at least two clinical evaluations. There were 146 subjects who met these criteria. The median age at initial diagnosis was 3.9 months, with a range of 1 day to 9.9 years. The average initial peak systolic gradient (PSG) was 23.3 mm Hg (+/-7.8) and final PSG 17.1 mm Hg (+/-10.3). Over a mean length of follow-up of 4.0 years, 107/146 (73%) were later reported to have very mild PVS (PSG < or = 25 mm Hg, no clinical change or resolution of murmur). Only 3 of 146 subjects progressed to have a PSG above 40 mm Hg, with 1 undergoing a balloon valvuloplasty. In conclusion, mild PVS diagnosed in early childhood is a benign lesion, with most children essentially demonstrating resolution in the first years of life. Mild PVS identified in infancy requires a brief period of close observation. Based on these data, our management recommendations are that infants be followed closely within the first year of life. Young infants diagnosed at birth that maintain a PSG < or = 25 mm Hg at more than 6 months of age as well as those who are older than 1 year of age with a PSG < or = 40 mm Hg have a benign course and the utility of ongoing cardiology follow-up is questionable.

Entities:  

Mesh:

Year:  2008        PMID: 18193316     DOI: 10.1007/s00246-007-9191-y

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  10 in total

1.  The natural history of uncomplicated valvular pulmonic stenosis.

Authors:  M R Mody
Journal:  Am Heart J       Date:  1975-09       Impact factor: 4.749

2.  THE FATE OF THE PATIENT WITH PULMONIC STENOSIS.

Authors:  M A ENGLE; T ITO; H P GOLDBERG
Journal:  Circulation       Date:  1964-10       Impact factor: 29.690

3.  Long-term psychologic implications of congenital heart disease: a 25-year follow-up.

Authors:  D J Brandhagen; R H Feldt; D E Williams
Journal:  Mayo Clin Proc       Date:  1991-05       Impact factor: 7.616

4.  Natural course of isolated pulmonary valve stenosis in infants and children utilizing Doppler echocardiography.

Authors:  D G Rowland; W W Hammill; H D Allen; H P Gutgesell
Journal:  Am J Cardiol       Date:  1997-02-01       Impact factor: 2.778

5.  Clinical course in pulmonary stenosis.

Authors:  E W Nugent; R M Freedom; J J Nora; R C Ellison; R D Rowe; A S Nadas
Journal:  Circulation       Date:  1977-08       Impact factor: 29.690

6.  Racial and temporal variations in the prevalence of heart defects.

Authors:  L D Botto; A Correa; J D Erickson
Journal:  Pediatrics       Date:  2001-03       Impact factor: 7.124

7.  Natural history of congenital pulmonary valvar stenosis: an echo and Doppler cardiographic study.

Authors:  H Gielen; O Daniëls; H van Lier
Journal:  Cardiol Young       Date:  1999-03       Impact factor: 1.093

8.  Guidelines for evaluation and management of common congenital cardiac problems in infants, children, and adolescents. A statement for healthcare professionals from the Committee on Congenital Cardiac Defects of the Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  D Driscoll; H D Allen; D L Atkins; J Brenner; A Dunnigan; W Franklin; H P Gutgesell; P Herndon; R E Shaddy; K A Taubert
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

9.  Second natural history study of congenital heart defects. Results of treatment of patients with pulmonary valvar stenosis.

Authors:  C J Hayes; W M Gersony; D J Driscoll; J F Keane; L Kidd; W M O'Fallon; D R Pieroni; R R Wolfe; W H Weidman
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

10.  A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects.

Authors:  M J Silka; B G Hardy; V D Menashe; C D Morris
Journal:  J Am Coll Cardiol       Date:  1998-07       Impact factor: 24.094

  10 in total
  3 in total

Review 1.  The Real Need for Regenerative Medicine in the Future of Congenital Heart Disease Treatment.

Authors:  Yuichi Matsuzaki; Matthew G Wiet; Brian A Boe; Toshiharu Shinoka
Journal:  Biomedicines       Date:  2021-04-27

2.  "Vanishing" pulmonary valve stenosis.

Authors:  Nofil I Arain; James H Moller; Lee A Pyles; Shanthi Sivanandam
Journal:  Ann Pediatr Cardiol       Date:  2012-01

3.  Cardiopulmonary Function Assessment in Children With Pulmonary Valve Stenosis.

Authors:  Li Yun Teng; Sen Wei Tsai; Chun Yuan Hsiao; Wei Hung Sung; Ko Long Lin
Journal:  Front Pediatr       Date:  2022-01-14       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.